Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Influence of Lifestyle and Genetic Risk Factors, Circulating Inflammatory Biomarkers and Menopausal Hormone Therapy on Long-term Prognosis After Postmenopausal Breast Cancer

NCT03401034 is registered in ClinicalTrials.gov with German Cancer Research Center as lead sponsor.

NCT NCT03401034
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03401034 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Influence of Lifestyle and Genetic Risk Factors, Circulating Inflammatory Biomarkers and Menopausal Hormone Therapy on Long-term Prognosis After Postmenopausal Breast Cancer
Lead sponsor
German Cancer Research Center
Phase
Observational
Overall status
Completed
Start date
August 1, 2002
Completion date
June 30, 2015
Enrollment
3,813 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, breast cancer mortality, breast cancer survival, genetic factors, hormone therapy, inflammation, inflammatory biomarkers, lifestyle, phytoestrogens, postmenopausal breast cancer